Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen A. Hill currently holds 12,750 shares of Cellectar Biosciences, Inc. (CLRB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen A. Hill has been a net buyer of CLRB stock. They have purchased $266.4K and sold $6.5K worth of shares.
Stephen A. Hill's most recent insider trade was on Dec 16, 2020, when they sold 7,500 shares at $0.00 per share.
Stephen A. Hill serves as Executive at Cellectar Biosciences, Inc. (CLRB). They have executed 17 insider transactions totaling $272.9K over their tenure at the company.
Stephen A. Hill holds the position of Executive at Cellectar Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Stephen A. Hill has shown a buying trading pattern, with $266.4K in total purchases and $6.5K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Stephen A. Hill was on Aug 28, 2015, when they sold $81.6K worth of CBIO shares. This transaction involved 12,146 shares at $6.72 per share.
Stephen A. Hill currently owns 12,750 shares of Cellectar Biosciences, Inc. (CLRB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen A. Hill's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen A. Hill has 17 Form 4 filings on record as an insider at Cellectar Biosciences, Inc..
Set alerts for Stephen A. Hill and 40,000+ other insiders.